Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya

Journal of Medical Virology

Volumn 81, Issue 6, 2009, Pages 1088-1093

  Piriou, Erwan ^a   Kimmel, Rhonda ^b   Chelimo, Kiprotich ^c   Middeldorp, Jaap M ^d   Odada, Peter Sumba ^c   Ploutz Snyder, Robert ^a,e   Moormann, Ann M ^b   Rochford, Rosemary ^a,f  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NASA HEADQUARTERS   (United States)

^f State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Burkitt's lymphoma; Co infection; EBV antibodies; Plasmodium falciparum

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ANTIBODY SPECIFICITY; ARTICLE; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; GROUPS BY AGE; HEALTH SURVEY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA; MIXED INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; VIRUS DETECTION; VIRUS REACTIVATION; BLOOD; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFANT; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION;

HUMAN HERPESVIRUS 4; PLASMODIUM FALCIPARUM;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT; KENYA; MALARIA; VIRUS ACTIVATION;

EID: 66449103663     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21485     Document Type: Article

References (22)

1. Carpenter LM, Newton R, Casabonne D, Ziegler J, Mbulaiteye S, Mbidde E, Wabinga H, Jaffe H, Beral V. 2008. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: A case-control study in Uganda. Int J Cancer 122:1319-1323.
2. Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, Zong YS, Ng MH. 2003. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105:706-709. (Pubitemid 36687741)
3. Chene A, Donati D, Guerreiro-Cacais AO, Levitsky V, Chen Q, Falk KI, Orem J, Kironde F, Wahlgren M, Bejarano MT. 2007. A molecular link between malaria and Epstein-Barr virus reactivation. PLoS Pathogens 3:e80. (Pubitemid 47015882)
4. Dalldorf G, Linsell CA, Barnhart FE, Martyn R. 1964. An epidemiologic approach to the lymphomas of African children and Burkitt's Sacroma of the Jaws. Perspect Biol Med 7:435-449.
5. de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W. 1978. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274:756-761.
6. Donati D, Zhang LP, Chene A, Chen Q, Flick K, Nystrom M, Wahlgren M, Bejarano MT. 2004. Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun 72:5412-5418. (Pubitemid 39223429)
7. Donati D, Espmark E, Kironde F, Mbidde EK, Kamya M, Lundkvist A, Wahlgren M, Bejarano MT, Falk KI. 2006a. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment. J Infect Dis 193:971-977.
8. Donati D, Mok B, Chene A, Xu H, Thangarajh M, Glas R, Chen Q, Wahlgren M, Bejarano MT. 2006b. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol 177:3035-3044. (Pubitemid 44277820)
9. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. 2006. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: Options for field screening. J Clin Microbiol 44:1459-1467.
10. Geser A, de The G, Lenoir G, Day NE, Williams EH. 1982. Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma. Int J Cancer 29:397-400. (Pubitemid 12159626)
11. Kafuko GW, Burkitt DP. 1970. Burkitt's lymphoma and malaria. Int J Cancer 6:1-9.
12. Komatsu N, Shichijo S, Nakagawa M, Itoh K. 2004. New multiplexed flow cytometric assay tomeasure anti-peptide antibody: A novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 64:535-545. (Pubitemid 39318358)
13. Miller G. 1990. Epstein-Barr virus: Biology, pathogenesis, and medical aspects. In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Hirsch MS, Monath TP, Roizman B, editors. Virology. New York: Raven Press, Ltd. pp 1921-1958.
14. Moormann AM, Chelimo K, Sumba OP, Lutzke ML, Ploutz-Snyder R, Newton D, Kazura J, Rochford R. 2005. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 191:1233-1238. (Pubitemid 40503650)
15. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW. 2007. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 195:799-808. (Pubitemid 46363924)
16. Mutalima N, Molyneux E, Jaffe H, Kamiza S, Borgstein E, Mkandawire N, Liomba G, Batumba M, Lagos D, Gratrix F, Boshoff C, Casabonne D, Carpenter LM, Newton R. 2008. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: Results from a case-control study. PLoS ONE 3:e2505.
17. Mwanda OW, Rochford R, Moormann AM, Macneil A, Whalen C, Wilson ML. 2004. Burkitt's lymphoma in Kenya: Geographical, age, gender and ethnic distribution. East Afr Med J 8(Suppl):S68-S77. (Pubitemid 41185456)
18. Rahman MA, Kingsley LA, Atchison RW, Belle S, Breinig MC, Ho M, Rinaldo CR, Jr. 1991. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin Microbiol 29:1215-1220.
19. Rainey JJ, Mwanda WO, Wairiumu P, Moormann AM, Wilson ML, Rochford R. 2007. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk. Trop Med Int Health 12:936-943. (Pubitemid 47245827)
20. Rasti N, Falk KI, Donati D, Gyan BA, Goka BQ, Troye-Blomberg M, Akanmori BD, Kurtzhals JA, Dodoo D, Consolini R, Linde A, Wahlgren M, Bejarano MT. 2005. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 61:461-465. (Pubitemid 40695017)
21. Rochford R, Cannon MJ, Moormann AM. 2005. Endemic Burkitt's lymphoma: A polymicrobial disease? Nature Rev 3:182-187.
22. Tedeschi R, Foong YT, Cheng HM, dePaoli P, Lehtinen T, Elfborg T, Dillner J. 1995. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J Gen Virol 76:1393-1400.